JENNIFER BASS: Open Payments
NPI 1962177519 · BROOKHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 19 payments from 9 companies in 2025. Trend: 2023 $464 · 2024 $546 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $92 |
| Corcept Therapeutics | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $54 |
| ABBVIE INC. | 3 | $48 |
| Lilly USA, LLC | 2 | $32 |
| Averitas Pharma Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Ascensia Diabetes Care Us Inc. | 1 | $17 |
| Ortho-Clinical Diagnostics, Inc. | 1 | $16 |
Products named: NURTEC ODT, Korlym, VRAYLAR, FARXIGA, AIRSUPRA, QUTENZA, INSPIRE, KISUNLA.
Industry payments across MS — which companies pay providers there.
